CU
Curaleaf Holdings, Inc.
CURLF · OTC
$9.88 +3.56% (+$0.34)
1M +5.76%
Market Cap $2.61B
P/E Ratio -
Div. Yield -
ROE 4.47%
Bulios Fair Price
$7.87
20.3% downside
Current Price
$9.88
Undervalued Fair Value Overvalued
According to Bulios Fair Price, CURLF is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
5/9Valuation
34 /100
Fair EV/EBITDA 25.09x
P/S 1.99x
P/B 3.01x
Growth
23 /100
Declining Rev. growth 1.75%
Book val. growth 16.12%
EPS growth N/A
Profitability
31 /100
Weak Gross margin 44.10%
Net margin 2.77%
Op. margin 0.91%
Quality
6 /100
Poor ROIC 0.10%
ROE 4.47%
ROA 1.30%
Debt
24 /100
High Debt/Equity 1.29x
Current ratio 1.52x
Int. coverage -0.37x
Stability
59 /100
Moderate Beta 1.63x
Rev. volatility 9.42%
EPS volatility 22.19%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about CURLF
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Boris Alexis Jordan
Employees
5,554
Headquarters
Stamford
Upcoming events
04 NOV
Earnings
Upcoming earnings report